SMB
Live / Applied — Second extension granted (statement of use) (as of 10 Feb 2026)
What this means for you
Not registered yet, but its 29 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98525292
- Mark type
- Stylized text
- Filed
- 29 Apr 2024
- Published for opposition
- 17 Dec 2024
- Attorney of record
- Jihun Kim
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; vitamins and mineral supplements; crude medicines for the treatment of gastrointestinal diseases; crude medicines, namely, medicinal preparations for use in dermatology; crude medicines, namely, plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; crude medicines, namely, medicines for treating neurological disease, muscular disease, ischemic disease, renal disease, and cancer; antibacterial pharmaceuticals; pharmaceutical products for the treatment of viral diseases; pharmaceutical products for the treatment of infectious diseases; diagnostic radiopharmaceutical preparations; pharmaceutical drugs for the treatment of metabolic disorders, namely, obesity, comorbidities secondary to obesity, metabolic syndrome, and related metabolic diseases; pharmaceutical drugs for the treatment of joint disorders and osteoarthritis; cough pastilles for pharmaceutical purposes; lotions for pharmaceutical purposes, namely, medicated skin lotions, medicated hair lotions, medicated sunburn lotions, calamine lotion, medicated after-shave lotions, collyrium, anti-bacterial hand lotions; chemical preparations for pharmaceutical use, namely, for the treatment of neurodegenerative disorders, neurological conditions, cancer, skin conditions, or for use in wound healing or photodynamic therapy; chemical preparations for pharmaceutical use, namely, for the treatment of fungal, viral, bacterial and infectious diseases
Owner
- CEN CO., LTD., Miryang-si, KR
- CEN CO., LTD., Miryang-si, KR
Prosecution history
- 11 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Feb 2026 — SOU EXTENSION 2 GRANTED
- 10 Feb 2026 — SOU EXTENSION 2 FILED
- 10 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2025 — SOU EXTENSION 1 GRANTED
- 28 Jul 2025 — SOU EXTENSION 1 FILED
- 28 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 20 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED